Skip to main content
. Author manuscript; available in PMC: 2009 Dec 3.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):459–466. doi: 10.1097/QAI.0b013e31815bace2

TABLE 3.

Step 2 Median (Range) Fasting Serum Lipid Values (mg/dL) on Combined Fenofibrate and Fish Oil

Step 2 Entry Week 18 Absolute Change P* Percent Change P*
Combined group overall (n = 67)
 TG 377 (205 to 1476) 279 (97 to 1458) −108 (−788 to 871) <0.001 −30% (−78 to 231) <0.001
 LDL-C 106 (60 to 214) 120 (49 to 216) 13 (−64 to 102) 0.002 13% (−45 to 117) 0.001
 HDL-C 32 (7 to 53) 33 (16 to 63) 2 (−13 to 27) 0.019 6% (−27 to 129) 0.019
 TC 237 (128 to 355) 220 (133 to 370) −5 (−87 to 59) 0.091 −2% (−33 to 27) 0.135
 Non-HDL-C 207 (100 to 314) 184 (98 to 318) −6 (−90 to 54) 0.034 −4% (−38 to 23) 0.054
Fish oil initiated first in step 1, adding fenofibrate at week 10 (n = 36)
 TG 369.5 (205 to 1278) 280 (97 to 1458) −92 (−616 to 871) <0.001 −28% (−71 to 231) <0.001
 LDL-C 101 (60 to 214) 119.5 (49 to 216) 11.5 (−64 to 102) 0.131 11% (−45 to 117) 0.026
 HDL-C 30.5 (22 to 51) 32.5 (21 to 63) 2 (−8 to 27) 0.057 8% (−25 to 75) 0.032
 TC 241 (128 to 355) 219.5 (133 to 342) −3 (−75 to 50) 0.247 −1% (−27 to 27) 0.314
 Non-HDL-C 211.5 (100 to 307) 183 (102 to 318) −7 (−69 to 49) 0.081 −4% (−32 to 23) 0.110
Fenofibrate initiated first in step 1, adding fish oil at week 10 (n = 31)
 TG 414 (206 to 1476) 279 (105 to 970) −117 (−788 to 176) <0.001 −36% (−78 to 49) <0.001
 LDL-C 116 (70 to 191) 120 (69 to 203) 13 (−29 to 61) 0.003 13% (−26 to 76) 0.004
 HDL-C 33 (7 to 53) 34 (16 to 58) 1 (−13 to 10) 0.170 3% (−27 to 129) 0.262
 TC 231 (166 to 321) 222 (137 to 370) −5 (−87 to 59) 0.239 −2% (233 to 19) 0.297
 Non-HDL-C 199 (136 to 314) 186 (98 to 312) −5 (−90 to 54) 0.236 −3% (−38 to 21) 0.302
*

Signed rank test.

TC indicates total cholesterol.